1. Ayscough N.J., Fawell J., Franklin G. and Young W.Review of Human Pharmaceuticalsinthe Environment. R&D Technical Report No. P390. Environment Agency, Bristol,UK,106pp (2000).
2. European Commission.Pollutants in Urban Wastewater and Sewage Sludge. Office for Official Publications of the European Community, Luxembourg City, Luxembourg, 232pp, (2001)
3. FDA Centre for Drug Evaluation and Research (CDER). Guidance for industry for the submission of an environmental assessment in human drug applications and supplements. Food and Drug Administration, Rockville, USA, 39pp. (1995).
4. EU. Assessment of potential risks to the environment posed by medicinal products for human use, excluding products containing live genetically modified organisms. EU ad hoc working party, III/5504/94 Draft 4, (1994)
5. Akingbemi B.T. and Hardy M.P. Oestrogenic and antiandrogenic chemicals in the environment: effects on male reproductive health.Ann. Med.33, 391–403, (2001)